Harold Edward Fleming

Insider Reports History

Location
Cambridge, MA
Signature
Jennifer Fitzpatrick, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harold Edward Fleming:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sionna Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 19,959 12 Jun 2025 Direct
Upstream Bio, Inc. Director Stock Option (Right to Buy) 17,096 10 Jun 2025 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13,000 05 Jun 2025 Direct

Insider Reports Filed by Harold Edward Fleming

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SION Sionna Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 17:07
UPB Upstream Bio, Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:17
CRSP CRISPR Therapeutics AG 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:30
SION Sionna Therapeutics, Inc. 06 Feb 2025 0 $0 3 Director 06 Feb 2025, 21:02
UPB Upstream Bio, Inc. 10 Oct 2024 1 $0 4 Director 15 Oct 2024, 16:15
UPB Upstream Bio, Inc. 10 Oct 2024 0 $0 3 Director 10 Oct 2024, 20:10
CRSP CRISPR Therapeutics AG 30 May 2024 1 $0 4 Director 31 May 2024, 16:15
CRSP CRISPR Therapeutics AG 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 17:34
CRSP CRISPR Therapeutics AG 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 17:36
CRSP CRISPR Therapeutics AG 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:35
CRSP CRISPR Therapeutics AG 10 Jun 2021 0 $0 3 Director 14 Jun 2021, 17:32